ITB: iShares U.S. Home Construction ETF returns, drawdowns and risk
Funds on a single sector of the US market: financials, energy, health care, industrials and more.
Data updated October 2026
ITB · US exchange · USDCategory: US sector ETFsData from October 2006
From October 2006 to October 2026 ITB returned 5.1% a year on average with dividends reinvested, in US dollars: $10,000 invested at the start grew to $26,910.
Its deepest fall was 84.9%, from February 2007 to March 2009, and it took about 130 months to get back to the previous high. Annual volatility was 35.3%; at the last close it was 30.5% below its high.
Against SPY (SPDR S&P 500 ETF Trust), over the 240 months both have data, the correlation of monthly returns was 0.67: they moved together only in part. Beta was 1.37. In months when SPY rose, ITB moved 115% as much on average; in months when SPY fell, 138% as much.
Key figures
- Annual return (CAGR)
- +5.1%
- 1-year return
- −14.9%
- 5 years, a year
- +5.1%
- 10 years, a year
- +13.4%
- Annual volatility
- 35.3%
- Maximum drawdown
- −84.9%
- Sharpe ratio
- 0.27
- Worst year
- 2007: −57.9%
Trailing returns
| Period | ITB | SPY |
|---|---|---|
| 1 year | −14.9% | +16.6% |
| 3 years, a year | +7.6% | +23.1% |
| 5 years, a year | +5.1% | +12.7% |
| 10 years, a year | +13.4% | +15.4% |
To the last close of October 2026. Periods longer than a year are annualised.
Growth of $10,000: ITB vs SPY
Month-end values from November 2006, the first month both funds have data.
ITB drawdowns
Percentage below the previous high, weekly.
Returns by calendar year
| Year | ITB | SPY |
|---|---|---|
| 2026(partial) | −8.4% | +13.3% |
| 2025 | −5.3% | +17.7% |
| 2024 | +2.1% | +24.9% |
| 2023 | +68.9% | +26.2% |
| 2022 | −26.3% | −18.2% |
| 2021 | +49.3% | +28.7% |
| 2020 | +26.4% | +18.3% |
| 2019 | +48.7% | +31.2% |
| 2018 | −30.9% | −4.6% |
| 2017 | +59.7% | +21.7% |
| 2016 | +1.8% | +12.0% |
| 2015 | +5.1% | +1.2% |
| 2014 | +4.7% | +13.5% |
| 2013 | +17.4% | +32.3% |
| 2012 | +79.3% | +16.0% |
| 2011 | −9.1% | +1.9% |
| 2010 | +10.4% | +15.1% |
| 2009 | +23.3% | +26.4% |
| 2008 | −43.0% | −36.8% |
| 2007 | −57.9% | +5.1% |
| 2006(partial) | +12.5% | — |
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
Sharpe ratio uses the return of short-term government bills in the same currency as the risk-free rate. The growth chart uses month-end values; drawdowns and volatility use daily closes.
Questions
What is the average annual return of ITB?
From October 2006 to October 2026 ITB returned 5.1% a year on average (CAGR) with dividends reinvested, in USD. Over the last 5 years: +5.1% a year. Over the last 12 months: −14.9%.
What was the worst drawdown of ITB?
84.9%, from February 2007 to March 2009; it took about 130 months from the previous high to get back to it.
How volatile is ITB?
Annual volatility was 35.3% over the period. Its worst month was −33.2% and 58% of months were positive. Worst calendar year: 2007 (−57.9%).
How closely does ITB follow SPY?
Over 240 months the correlation of monthly returns was 0.67, so they moved together only in part, with a beta of 1.37.
Use ITB in a free tool
Other US sector ETFs
- All US sector ETFsReturns and risk side by side
- XLF — Financial Select Sector SPDR FundCAGR +16.3%
- XLV — Health Care Select Sector SPDR FundCAGR +11.0%
- XLI — Industrial Select Sector SPDR FundCAGR +10.3%
- XLP — Consumer Staples Select Sector SPDR FundCAGR +9.2%
- XLC — Communication Services Select Sector SPDR FundCAGR +12.7%
- VHT — Vanguard Health Care ETFCAGR +10.3%
- VFH — Vanguard Financials ETFCAGR +16.5%
- VDE — Vanguard Energy ETFCAGR +26.4%
- IBB — iShares Biotechnology ETFCAGR +11.2%
- XBI — SPDR S&P Biotech ETFCAGR +6.2%
- KRE — SPDR S&P Regional Banking ETFCAGR +4.4%
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.